75 related articles for article (PubMed ID: 9790068)
1. Expression of mdm-2 protein in neoplastic, preneoplastic, and normal bronchial mucosa specimens: comparative study with p53 expression.
Rasidakis A; Orphanidou D; Kalomenidis J; Papamichalis G; Toumbis M; Lambaditis J; Sacharidou A; Papastamatiou H; Jordanoglou J
Hybridoma; 1998 Aug; 17(4):339-45. PubMed ID: 9790068
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of p53 protein in neoplastic, preneoplastic and normal bronchial mucosa specimens obtained during diagnostic bronchoscopy.
Orfanidou D; Kalomenidis J; Rasidakis A; Papamichalis G; Toumbis M; Labaditis J; Sacharidou A; Papastamatiou H; Jordanoglou J
Oncol Rep; 1998; 5(3):763-9. PubMed ID: 9538190
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
4. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
[TBL] [Abstract][Full Text] [Related]
6. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
[TBL] [Abstract][Full Text] [Related]
7. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo.
Van Gijssel HE; Ohlson LC; Torndal UB; Mulder GJ; Eriksson LC; Porsch-Hällström I; Meerman JH
Hepatology; 2000 Oct; 32(4 Pt 1):701-10. PubMed ID: 11003613
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Mdm2 and p53 in penile verrucous carcinoma.
Ouban A; Dellis J; Salup R; Morgan M
Ann Clin Lab Sci; 2003; 33(1):101-6. PubMed ID: 12661905
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 in preneoplastic and early neoplastic bronchial lesions.
Martin B; Verdebout JM; Mascaux C; Paesmans M; Rouas G; Verhest A; Ninane V; Sculier JP
Oncol Rep; 2002; 9(2):223-9. PubMed ID: 11836584
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
12. Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions.
Ferron PE; Bagni I; Guidoboni M; Beccati MD; Nenci I
Tumori; 1997; 83(2):587-93. PubMed ID: 9226026
[TBL] [Abstract][Full Text] [Related]
13. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma.
Gorgoulis VG; Zoumpourlis V; Rassidakis GZ; Karameris A; Rassidakis AN; Spandidos DA; Kittas C
J Pathol; 1996 Oct; 180(2):129-37. PubMed ID: 8976869
[TBL] [Abstract][Full Text] [Related]
14. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis.
Girod SC; Cesarz D; Fischer U; Krueger GR
Anticancer Res; 1995; 15(4):1453-7. PubMed ID: 7654034
[TBL] [Abstract][Full Text] [Related]
15. A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers.
Satoh Y; Ishikawa Y; Nakagawa K; Hirano T; Tsuchiya E
Br J Cancer; 1997; 75(5):678-83. PubMed ID: 9043024
[TBL] [Abstract][Full Text] [Related]
16. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K
Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493
[TBL] [Abstract][Full Text] [Related]
17. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
Emanuels AG; Koudstaal J; Burger MP; Hollema H
Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783
[TBL] [Abstract][Full Text] [Related]
20. Modulation of neoangiogenesis in bronchial preneoplastic lesions.
Fontanini G; Calcinai A; Boldrini L; Lucchi M; Mussi A; Angeletti CA; Cagno C; Tognetti MA; Basolo F
Oncol Rep; 1999; 6(4):813-7. PubMed ID: 10373662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
